Table 6.
Patients With Occurrences of Bleeding Endpoints and Their Components
| Vorapaxar (n=6446) (%) | Placebo (n=6441) (%) | |
|---|---|---|
| Patients with occurrence of GUSTO moderate or severe bleeding | ||
| 1 | 362 (5.6) | 274 (4.3) |
| 2 | 27 (0.4) | 16 (0.2) |
| 3 | 2 (0.03) | 0 (0.0) |
| Patients with occurrence of TIMI clinically significant bleeding | ||
| 1 | 878 (13.6) | 678 (10.5) |
| 2 | 149 (2.3) | 66 (1.0) |
| 3 | 30 (0.5) | 11 (0.2) |
| 4 | 5 (0.08) | 0 (0.0) |
| 5 | 3 (0.05) | 0 (0.0) |
Data presented as n (%). GUSTO indicates Global Use of Strategies to Open Occluded Coronary Arteries; TIMI, Thrombolysis in Myocardial Infarction.